Its products include the cancer treatment Darzalex, a COVID-19 vaccine and medical devices for

Growing prescription drug and medical device sales nudged Johnson Johnson past fourth-quarter earnings expectations, and the health care giant's COVID-19 vaccine gained momentum as well.JJ's one-shot vaccine rang up$ 1.62 billion in sales in the last quarter of 2021, or more than double what it had recorded before the quarter, as drugstores and clinics started doling out booster shots. The vaccine wound up bringing in$ 2.38 billion last year, or slightly less than what company leaders have said

Johnson Johnson is peeling off a consumer health business that helped it become the world’s biggest healthcare products maker. The company said Friday that it will separate its segment that sells Band-Aids, Listerine and over-the-counter medicines such as Tylenol from its pharmaceutical and medical device businesses. Company leaders told analysts that the split, which will create another publicly traded company for the consumer health side, will make each business more nimble in adapting to its